Synchrony Financial (SYF) director reports 660-share equity grant
Rhea-AI Filing Summary
Synchrony Financial reported that one of its directors acquired additional equity through a stock-based award. On December 31, 2025, the director received 660 shares of common stock, shown at a price of $83.43 per share, bringing the director’s directly held beneficial ownership to 30,529 shares after the transaction.
An explanation clarifies that this award represents restricted stock units that will vest in full on December 31, 2026, with each unit converting into one share of Synchrony Financial common stock when vested. This filing reflects routine director compensation in the form of equity rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 660 | $83.43 | $55K |
Footnotes (1)
- F1. Represents restricted stock units that will vest in full on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Synchrony Financial (SYF) report in this Form 4?
The filing shows that a director of Synchrony Financial acquired 660 shares of common stock as part of an equity award on December 31, 2025.
What type of equity award did the Synchrony Financial director receive?
The award consists of restricted stock units, each representing a contingent right to receive one share of Synchrony Financial common stock upon vesting.
When do the restricted stock units reported by Synchrony Financial vest?
The restricted stock units will vest in full on December 31, 2026, at which time each unit is expected to convert into one share of common stock.
At what price is the Synchrony Financial director’s equity award shown in the Form 4?
The 660-share award is reported at a price of $83.43 per share for Synchrony Financial common stock.